Next UK Drug Pricing Scheme Needs ‘Single-Digit Fixed Rebates’

 
• By Leela Barham

The pharmaceutical industry and the UK government are beginning a series of discussions on the shape of the future voluntary drug pricing and access scheme (VPAS), ahead of the formal negotiations that are scheduled to start in April.

Choosing the correct pathway, difficult decision concept,
Which way now for the UK's voluntary pricing and access scheme? • Source: Shutterstock

More from Europe

More from Geography